Experiment 642519

Compounds isolated

Details

PropertyValue
Pharmacology
Administration routeINTRACAVERNOUS
OrganismEmpty organism
CitationBROWN,SL: HAAS,CA: KOEHLER,M: BODNER,DR: SEFTEL,AD:. (1998). HEPATOTOXICITY RELATED TO INTRACAVERNOUS PHARMACOTHERAPY WITH PAPAVERINE.. 52(5)
Amount utilized
Compound isolated
DiseaseVS.HAVE LIVER DISEASE BEFORE BEGINNING THERAPY; LFTS.
Dose amount20.0 MG
Number2
Qualitative resultACTIVE
AnimalHUMAN ADULT
Per unitPERSON
Dose expressionDOSE
GenderMALE